Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01995045 · ClinicalTrials.gov registry record · Phase 4
Postoperative Pain Control Following Vitreoretinal Surgery
A Phase 4 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 4
- Development phase
- 58
- Enrollment target
NCT01995045 is a Phase 4 study that has completed, run by Emory University. The registered enrollment target is 58 participants.
The verdict
NCT01995045, a Phase 4 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 58 participants
- Enrollment target
Study Summary
The aim of this study is to evaluate if patients receiving a steroid (triamcinolone acetonide) combined with local anesthesia and antibiotic following retina surgery have better postoperative pain control those receiving local anesthesia and antibiotic alone.
Interventions
- DRUG Triamcinolone
- DRUG Bupivicaine Hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2012-07 |
| Est. Completion | 2015-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01995045
The ClinicalTrials.gov registry entry for NCT01995045 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Triamcinolone is the first listed.
NCT01995045 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01995045 about?
NCT01995045 is a clinical study titled "Postoperative Pain Control Following Vitreoretinal Surgery". The aim of this study is to evaluate if patients receiving a steroid (triamcinolone acetonide) combined with local anesthesia and antibiotic following retina surgery have better postoperative pain control those receiving local anesthesia and antibiotic alone.
What is the current status of trial NCT01995045?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 58 participants. The study started on 2012-07. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01995045?
The interventions under investigation include: Triamcinolone (DRUG), Bupivicaine Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT01995045?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.